Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP).
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $3.6B | $3.5B | $3.3B | $3.3B | $3.2B | $2.8B | $2.4B | $2.5B | $2.5B | $2.3B | $2.1B | $2.0B | $2.1B | $2.0B | $2.0B | $1.8B | $1.5B | $1.3B | $1.5B | $1.4B | $1.2B |
| Bruttoergebnis | $1.6B | $1.5B | $1.5B | $1.4B | $1.6B | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B | $985M | $941M | $987M | $908M | $840M | $791M | $650M | $551M | $627M | $597M | $502M |
| Bruttomarge % | 44.7% | 44.5% | 46.4% | 44.2% | 50.1% | 49.2% | 49.2% | 51.1% | 46.9% | 46.7% | 46.6% | 46.6% | 46.0% | 44.9% | 43.0% | 43.0% | 43.0% | 41.4% | 42.1% | 43.9% | 43.5% |
| Betriebsergebnis (EBIT) | $747M | $720M | $697M | $732M | $790M | $654M | $537M | $602M | $584M | $503M | $451M | $431M | $448M | $399M | $359M | $339M | $260M | $196M | $254M | $255M | $217M |
| Operative Marge % | 20.8% | 20.8% | 21.3% | 22.4% | 24.8% | 23.6% | 22.8% | 24.1% | 23.5% | 22.0% | 21.3% | 21.3% | 20.8% | 19.7% | 18.4% | 18.5% | 17.2% | 14.7% | 17.1% | 18.8% | 18.8% |
| Jahresüberschuss | $519M | $483M | $505M | $596M | $587M | $449M | $378M | $426M | $411M | $337M | $271M | $283M | $279M | $255M | $38M | $194M | $157M | $113M | $131M | $155M | $147M |
| Nettomarge % | 14.5% | 14.0% | 15.4% | 18.2% | 18.4% | 16.2% | 16.1% | 17.1% | 16.5% | 14.7% | 12.8% | 14.0% | 13.0% | 12.6% | 1.9% | 10.5% | 10.4% | 8.5% | 8.8% | 11.4% | 12.7% |
| EBITDA | — | $904M | $859M | $732M | $910M | $720M | $605M | $648M | $657M | $591M | $508M | $505M | $504M | $467M | $199M | $369M | $306M | $234M | $260M | $290M | $247M |
| Ergebnis je Aktie (EPS) | $6.96 | $6.42 | $6.65 | $7.85 | $7.72 | $5.88 | $4.95 | $5.57 | $5.29 | $4.36 | $3.53 | $3.63 | $3.46 | $3.09 | $0.45 | $2.32 | $1.92 | $1.40 | $1.60 | $1.89 | $1.81 |
| Ausstehende Aktien (Mio.) | — | 75M | 76M | 76M | 76M | 76M | 76M | 76M | 78M | 77M | 77M | 78M | 81M | 82M | 84M | 84M | 82M | 81M | 82M | 82M | 81M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für IEX. /companies/us/IEX
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms